Skip to main content
. 2014 Jun 23;7:211–223. doi: 10.2147/DMSO.S50789

Table 1.

Summary of current clinical trials with refinements in islet transplantation

Category Trial ID Description Institution Estimated completion date
Islet alone NCT00434811 Islet transplantation in type 1 diabetes – phase 3 (CIT-07) National Institute of Allergy and Infectious Diseases May 2014
Islet – Kidney NCT01123187 Islet cell transplantation in patients with type 1 diabetes with previous kidney transplantation University Hospital, Lille March 2015
NCT01241864 Islet transplantation in type 1 diabetic kidney allograft University of Chicago December 2016
NCT01705899 Islet allotransplantation in type 1 diabetes: phase I trial comparing islet alone vs islet after kidney transplantation Ohio State University May 2017
NCT00784966 Islet after kidney transplant for type 1 diabetes Virginia Commonwealth University September 2017
NCT00468117 Efficacy of islet after kidney transplantation – phase 3 (CIT-06) National Institute of Allergy and Infectious Diseases December 2018
Alternative transplant sites NCT00790257 Safety and efficacy study of encapsulated human islets allotransplantation to treat type 1 diabetes (subcutaneous space) Cliniques universitaires Saint Luc Université Catholique de Louvain December 2013
NCT01722682 Bone marrow versus liver as site for islet transplantation Ospedale San Raffaele November 2014
NCT01652911 A phase I/II study of the safety and efficacy of sernova’s Cell Pouch™ for therapeutic islet transplantation (subcutaneous space) University of Alberta December 2014
NCT01379729 Functional survival of beta cell allografts after transplantation in the peritoneal cavity of non-uremic type 1 diabetic patients Ziekenhuis Brussel/Ziekenhuizen Leuven Belgium May 2018
Complications NCT01148680 Trial comparing metabolic efficiency of islet graft to intensive insulin therapy for type 1 diabetes treatment University Hospital, Grenoble December 2014
NCT00853424 A comparison of islet cell transplantation with medical therapy for the treatment of diabetic eye disease University of British Columbia June 2015
Refined portal vein protocols NCT00679042 Islet transplantation in type 1 diabetic patients using the University of Illinois at Chicago protocol University of Illinois December 2013
NCT00789308 Safety and effectiveness of low molecular weight sulfated dextran in islet transplantation National Institute of Allergy and Infectious Diseases August 2014
NCT01817959 Study to assess efficacy and safety of reparixin in pancreatic islet transplantation Multi-Centers International November 2014
NCT00530686 Pancreatic islet cell transplantation – a novel approach to improve islet quality and engraftment Baylor Research Institute December 2014
NCT01653899 Caspase inhibition in islet transplantation University of Alberta June 2015
NCT01897688 A phase 2 single center study of islet transplantation in non-uremic diabetic patients Northwestern University June 2015
NCT01186562 Sitagliptin therapy to improve outcomes after islet autotransplant University of Minnesota September 2015
NCT01630850 Islet transplantation in patients with (brittle) type 1 diabetes University of Chicago June 2019
NCT01974674 Allogeneic islet transplantation for the treatment of type 1 diabetes (GRIIF) Assistance Publique – Hôpitaux de Paris January 2021
NCT01909245 Islet cell transplant for type 1 diabetes (TCD) City of Hope Medical Center July 2021
Alternative cellular therapies NCT00646724 Co-transplantation of islet and mesenchymal stem cell in type 1 diabetic patients Fuzhou General Hospital January 2014
NCT01350219 Stem cell educator therapy in type 1 diabetes Tianhe Stem Cell Biotechnologies Inc. September 2014
NCT01736228 Open-label investigation of the safety and efficacy of DIABECELL in patients with T1DM: xenotransplantation of encapsulated porcine islets into the peritoneal cavity Living Cell Technologies December 2014
NCT01341899 Efficacy and safety study of autologous hematopoietic stem cell transplantation to treat new onset type 1 diabetes Nanjing University Medical School December 2015
NCT01285934 A trial of high dose immunosuppression and autologous hematopoietic stem cell support versus intensive insulin therapy in adults with early onset T1DM University of Sao Paulo General Hospital December 2016

Abbreviations: CIT, Clinical Islet Transplant; GRIIF, allogeneic islet transplantation for the treatment of type 1 diabetes; T1DM, type I diabetes mellitus; TCD, T-cell depletion.